SCHEMBL30459542

SCHEMBL30459542

COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.70
KDR P35968 13/20 0.64
RET P07949 11/20 0.64
KIF5B P33176 9/20 0.64
ERBB2 P04626 5/20 0.61
EPHA2 P29317 4/20 0.61
EPHB4 P54760 4/20 0.61
FLT1 P17948 3/20 0.61
EPHB2 P29323 3/20 0.60
RIPK2 O43353 2/20 0.60
EPHA4 P54764 2/20 0.60
BTK Q06187 2/20 0.60
RIPK3 Q9Y572 2/20 0.60
GAK O14976 1/20 0.60
EPHB6 O15197 1/20 0.60
STK10 O94804 1/20 0.60
MAP4K4 O95819 1/20 0.60
ABL1 P00519 1/20 0.60
LCK P06239 1/20 0.60
YES1 P07947 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14843536 1.00 EGFR (0.70) EGFRKDRRETKIF5BERBB2
SCHEMBL29453257 1.00 EGFR (0.70) EGFRKDRRETKIF5BERBB2
Hydrochloric Acid SCHEMBL28257165 0.99 EGFR (0.69) EGFRKDRRETKIF5BERBB2
SCHEMBL6018368 0.96 EGFR (0.68) EGFRKDRRETKIF5BERBB2
Hydrochloric Acid SCHEMBL907165 0.95 EGFR (0.67) EGFRKDRRETKIF5BERBB2
SCHEMBL16075710 0.91 EGFR (0.70) EGFRKDRRETKIF5BFLT1
SCHEMBL17179538 0.91 EGFR (0.70) EGFRKDRRETKIF5BERBB2
SCHEMBL25478232 0.89 KDR (0.65) EGFRKDRRETKIF5BERBB2
Trifluoroacetic Acid SCHEMBL907408 0.88 EGFR (0.65) EGFRKDRRETKIF5BERBB2
SCHEMBL19124214 0.88 EGFR (0.67) EGFRKDRRETKIF5BERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4446324-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2024-10-16 EP disclosed
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 WO disclosed